This Korean company is specialized in the manufacturing of optical components for over 16 years. This company has been developing new technologies related between optics and healthcare based on its own specialty.
The main technology of this product is a multi-wave laser which is based on low-level laser therapy (LLLT). Low light level laser therapy supports the body to increase the number of cells by irradiating the light to facilitate the blood volume, oxygen supply and nutrient supply of cells. This helps the blood flow to be normalized with the reduction of chronic inflammation. Comparing with medication which is the most common treatment for nasal inflammation patients don't need to take the medicine continuously. Furthermore, this product supplements the limitation of current laser treatment which is that the inflammation could relapse over time as single-wave lasers are limited to irradiate inside the nostril. On the other hand, multi-wave lasers can cure the inflammation in the nostril as well as the nasal cavity. The wavelength of laser light is 670 mm at one point and 830 mm of multi-waves. This wavelength of laser light stimulates cells inside the nose to relieve the inflammation especially because of the hypersensitive response. The effects come out when patients use this product for about 1 month.
The product was developed in 2010, and is currently being sold in Korea and Thailand as well. More recently, it is under test in Vietnam for market entry as well. In line with the company's goal to expand in the global market, they are also seeking for a partner in Europe who is closely linked to otolaryngology or a drugstore to enter into a distribution services agreement.